MedPath

Measurement of biochemical markers of bone turnover in patients with bilateral sagittal split osteotomy

Completed
Conditions
bone specific markers in urine and serum
10005959
Registration Number
NL-OMON36318
Lead Sponsor
niversitair Medisch Centrum Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

Patients for Bilateral Sagittal split Osteotomy
Over 18 years old

Exclusion Criteria

Renal and liver function problems
Active treatment with growth hormone
Patients with Hormone replacement therapy
Breastfeeding
Pregnancy
The use of anti-epileptics
Astma patients that use inhalation steroids
The use of anticoagulentia

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Primary Objective:<br /><br>- Are there mesurable changes in biochemical markers after BSSO in serum(CTX,<br /><br>P1NP, BALP, Osteocalcine, Calcium, vit D. CRP, BSE, leucocyten, IL6,<br /><br>creatine) and in urine(hydroxylysylpyridinoline en lysyspyridinoline)?<br /><br>- Can serum and urine biochemical markers predict bone remodeling?</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>None</p><br>
© Copyright 2025. All Rights Reserved by MedPath